John Paulson Takeda Pharmaceutical CO LTD Transaction History

Paulson & Co. Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$16.55 - $18.64 $78.2 Million - $88.1 Million	-4,727,415 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$16.71 - $19.9 $110 Million - $131 Million	-6,568,431 Reduced 58.15%	4,727,415 $86.3 Million
Q3 2020 Nov 16, 2020	SELL	$17.1 - $19.19 $3.27 Million - $3.67 Million	-191,059 Reduced 1.66%	11,295,846 $202 Million
Q2 2020 Aug 14, 2020	SELL	$14.59 - $19.5 $25.6 Million - $34.3 Million	-1,757,806 Reduced 13.27%	11,486,905 $206 Million
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $221 Million - $285 Million	13,244,711 New	13,244,711 $270 Million

338

76.2M

1.85M

121K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.5B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Paulson & Co. Inc., based on Form 13F filings with the SEC.

Stay updated on Paulson & Co. Inc. and John Paulson with notifications on news.